H. Lundbeck A/S:企業の戦略・SWOT・財務情報

◆英語タイトル:H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C15504
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

H. Lundbeck A/S – Strategy, SWOT and Corporate Finance Report
Summary

H. Lundbeck A/S – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

H. Lundbeck A/S (Lundbeck or ‘the company’) is a specialty pharmaceutical company primarily focusing on brain diseases. The company’s products are focused on treating depression/anxiety, Alzheimer’s disease, schizophrenia, alcohol dependence, Parkinson’s disease, epilepsy (including lennox-gastaut syndrome), huntington’s disease, psychotic disorders, symptomatic neurogenic orthostatic hypotension and bipolar disorders. Lundbeck’s brands include Abilify Maintena, Abixa, Azilect, Brintellix, Celexa and Cipralex. Lundbeck manages its manufacturing facilities in China, Italy, Denmark and France. The company sells its products to hospitals, pharmacies, and other distributors. The company is headquartered in Valby, Denmark.

Scope

- Detailed information on H. Lundbeck A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting H. Lundbeck A/S in the form of a SWOT analysis
- An in-depth view of the business model of H. Lundbeck A/S including a breakdown and examination of key business segments
- Intelligence on H. Lundbeck A/S’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about H. Lundbeck A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of H. Lundbeck A/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess H. Lundbeck A/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on H. Lundbeck A/S’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
H. Lundbeck A/S: Company Overview
H. Lundbeck A/S: Overview and Key Facts
H. Lundbeck A/S: Overview
H. Lundbeck A/S: Key Facts
H. Lundbeck A/S: Key Employees
H. Lundbeck A/S: Key Employee Biographies
H. Lundbeck A/S: Major Products and Services
H. Lundbeck A/S: Company History
H. Lundbeck A/S: Management Statement
H. Lundbeck A/S: Locations and Subsidiaries
H. Lundbeck A/S: Key Competitors
H. Lundbeck A/S: Company Analysis
H. Lundbeck A/S: Business Description
H. Lundbeck A/S: SWOT Analysis
H. Lundbeck A/S: SWOT Overview
H. Lundbeck A/S: Strengths
H. Lundbeck A/S: Weaknesses
H. Lundbeck A/S: Opportunities
H. Lundbeck A/S: Threats
H. Lundbeck A/S: Corporate Financial Deals Activity
H. Lundbeck A/S: Financial Deals Overview
H. Lundbeck A/S: Targets and Partners
H. Lundbeck A/S: Top Deals 2015 – 2019YTD*
H. Lundbeck A/S: Advisors
H. Lundbeck A/S: Top Legal Advisors
H. Lundbeck A/S: Mergers and Acquisitions
H. Lundbeck A/S: Partnership
H. Lundbeck A/S: Divestments
H. Lundbeck A/S: Recent Developments
H. Lundbeck A/S: News and Events Summary
H. Lundbeck A/S: Contracts
H. Lundbeck A/S: Corporate Governance
H. Lundbeck A/S: Financial Deals
H. Lundbeck A/S: Financial Performance
H. Lundbeck A/S: Market Developments
H. Lundbeck A/S: Regulatory and Legal Events
H. Lundbeck A/S: Research & Development
H. Lundbeck A/S: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: H. Lundbeck A/S: Key Facts
Table 2: H. Lundbeck A/S: Key Employees
Table 3: H. Lundbeck A/S: Company History
Table 4: H. Lundbeck A/S: Locations and Subsidiaries
Table 5: H. Lundbeck A/S: Key Competitors
Table 6: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (TTM*)
Table 7: H. Lundbeck A/S: M&A Activity by Geography (TTM*)
Table 8: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: H. Lundbeck A/S: M&A Average Deal Size - Value (US$m)
Table 10: H. Lundbeck A/S: Targets and Partners
Table 11: H. Lundbeck A/S: Top Deals 2015 - 2019YTD*
Table 12: H. Lundbeck A/S: Legal Advisor Ranking by Value (US$m)
Table 13: H. Lundbeck A/S: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: H. Lundbeck A/S: M&A Activity by Geography (2015 - YTD*2019)
Table 15: H. Lundbeck A/S: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 16: H. Lundbeck A/S: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 17: H. Lundbeck A/S: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 18: H. Lundbeck A/S: News and Events Summary
Table 19: H. Lundbeck A/S: Contracts
Table 20: H. Lundbeck A/S: Corporate Governance
Table 21: H. Lundbeck A/S: Financial Deals
Table 22: H. Lundbeck A/S: Financial Performance
Table 23: H. Lundbeck A/S: Market Developments
Table 24: H. Lundbeck A/S: Regulatory and Legal Events
Table 25: H. Lundbeck A/S: Research & Development
Table 26: H. Lundbeck A/S: Strategy and Operations

List of Figures
Figure 1: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: H. Lundbeck A/S: M&A Activity by Geography (TTM*)
Figure 3: H. Lundbeck A/S: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: H. Lundbeck A/S: M&A Average Deal Size - Value (US$m)
Figure 5: H. Lundbeck A/S: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: H. Lundbeck A/S: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: H. Lundbeck A/S: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 8: H. Lundbeck A/S: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 9: H. Lundbeck A/S: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[H. Lundbeck A/S:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Theranostics Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • Nexans SA (NEX):電力:M&Aディール及び事業提携情報
    Summary Nexans SA (Nexans) is a provider of cables and connectivity solutions. The company offers copper and fiber optic cables and cabling systems. It serves network operators, equipment and infrastructure manufacturers, and builders, installers and distributors in submarine and land, oil and gas, …
  • Balfour Beatty plc:企業の戦略・SWOT・財務情報
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Exponent Inc (EXPO):企業の財務・戦略的SWOT分析
    Summary Exponent Inc (Exponent), formerly Failure Analysis Associates Inc, is an engineering and scientific consulting company that provides technical solutions. The company provides engineering services in biomechanics, buildings and structures, biomedical engineering, civil engineering, electrical …
  • MDNA Life Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • GC Pharma (006280):企業の財務・戦略的SWOT分析
    GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Akzo Nobel NV (AKZA):企業の財務・戦略的SWOT分析
    Akzo Nobel NV (AKZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • GenomicTree Co Ltd (228760):企業の製品パイプライン分析
    Summary GenomicTree Co Ltd (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic product. Its products are used in the detection of colorectal, lung …
  • Breas Medical AB:医療機器:M&Aディール及び事業提携情報
    Summary Breas Medical AB (Breas), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co Ltd, is a medical device company that manufactures and markets medical devices for anesthesia and respiratory markets. The company provides isleep and vivo products. It provides products such as isleep, vivo 3 …
  • Ygm Trading Ltd.:企業の戦略・SWOT・財務分析
    Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Shanghai Electric Power Co Ltd (600021):企業の財務・戦略的SWOT分析
    Summary Shanghai Electric Power Co., Ltd. (Shanghai Electric Power), a subsidiary of State Power Investment Corporation is an electric energy company that generates and supplies electricity and thermal power. The company generates electricity from coal-fired plants, gas-fired plants, IGCC, gas power …
  • SIGA Technologies Inc (SIGA):企業の財務・戦略的SWOT分析
    Summary Siga Technologies Inc (Siga) a subsidiary of MacAndrews and Forbes Holdings Inc, is a health security service provider. The company develops and commercialise solutions for serious unmet medical needs and bio threats. It offers antiviral drug to treat smallpox disease. Siga offers product su …
  • SPAR Osterreichische Warenhandels AG:企業の戦略的SWOT分析
    SPAR Osterreichische Warenhandels AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • FirstRand Ltd (FSR):企業の財務・戦略的SWOT分析
    FirstRand Ltd (FSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nexeon MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes devices and therapies for the treatment of cardiovascular diseases. The company’s products include embolic protection systems, local drug and biologic delivery systems, nanotechnology-based devices, a …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務分析
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Absher Construction Company:企業の戦略・SWOT・財務情報
    Absher Construction Company - Strategy, SWOT and Corporate Finance Report Summary Absher Construction Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Transgenomic Inc (TBIO)-医療機器分野:企業M&A・提携分析
    Summary Transgenomic Inc (Transgenomic) is a developer and provider of diagnostic tools and services. The company’s products include ICEme Kits, and genetic assays and platforms. It offers genetic assays and platforms such as PCR reagents, chromatography, genetic analysis kits, hanabi cytogenetic sy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆